<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">dan</journal-id><journal-title-group><journal-title xml:lang="ru">Доклады Национальной академии наук Беларуси</journal-title><trans-title-group xml:lang="en"><trans-title>Doklady of the National Academy of Sciences of Belarus</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1561-8323</issn><issn pub-type="epub">2524-2431</issn><publisher><publisher-name>The Republican Unitary Enterprise Publishing House "Belaruskaya Navuka"</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.29235/1561-8323-2022-66-5-509-516</article-id><article-id custom-type="elpub" pub-id-type="custom">dan-1090</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БИОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BIOLOGY</subject></subj-group></article-categories><title-group><article-title>Гетерологичная экспрессия диаденилатциклазы в виде телец включения, обладающих ферментативной активностью</article-title><trans-title-group xml:lang="en"><trans-title>Heterologous expression of diadenylate cyclase in the form of inclusion bodies with enzymatic activity</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Винтер</surname><given-names>М. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Vinter</surname><given-names>M. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Винтер Маргарита Андреевна – мл. науч. сотрудник</p><p>ул. Купревича, 2, 220141, Минск</p></bio><bio xml:lang="en"><p>Vinter Margarita A. – Junior Researcher</p><p>2, Kuprevich Str., 220141, Minsk</p></bio><email xlink:type="simple">rita.vinter.abc@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Казловский</surname><given-names>И. С.</given-names></name><name name-style="western" xml:lang="en"><surname>Kazlouski</surname><given-names>I. S.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Казловский Илья Сергеевич – канд. биол. наук, науч.сотрудник</p><p>ул. Купревича, 2, 220141, Минск</p></bio><bio xml:lang="en"><p>Kazlouski Illia S. – Ph. D. (Biology), Researcher</p><p>2, Kuprevich Str., 220141, Minsk</p></bio><email xlink:type="simple">kazlouski.illia@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-2401-2586</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Зинченко</surname><given-names>А. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Zinchenko</surname><given-names>A. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Зинченко Анатолий Иванович – член-корреспондент, д-р биол. наук, профессор, заведующий лабораторией</p><p>ул. Купревича, 2, 220141, Минск</p></bio><bio xml:lang="en"><p>Zinchenko Anatoliy I. – Corresponding Member, D. Sc. (Biology), Professor, Head of the Laboratory</p><p>2, Kuprevich Str., 220141, Minsk</p></bio><email xlink:type="simple">zinch@mbio.bas-net.by</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Институт микробиологии Национальной академии наук Беларуси</institution></aff><aff xml:lang="en"><institution>Institute of Microbiology of the National Academy of Sciences of Belarus</institution></aff></aff-alternatives><pub-date pub-type="collection"><year>2022</year></pub-date><pub-date pub-type="epub"><day>03</day><month>11</month><year>2022</year></pub-date><volume>66</volume><issue>5</issue><fpage>509</fpage><lpage>516</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Винтер М.А., Казловский И.С., Зинченко А.И., 2022</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="ru">Винтер М.А., Казловский И.С., Зинченко А.И.</copyright-holder><copyright-holder xml:lang="en">Vinter M.A., Kazlouski I.S., Zinchenko A.I.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://doklady.belnauka.by/jour/article/view/1090">https://doklady.belnauka.by/jour/article/view/1090</self-uri><abstract><p>С помощью техники рекомбинантной ДНК создан новый бактериальный штамм Escherichia coli ДАЦ-22, клетки которого способны осуществлять гетерологичную экспрессию диаденилатциклазы Bacillus thuringiensis – фермента, катализирующего реакцию трансформации аденозин-5′-трифосфата в циклический 3′,5′-диаденилат (цикло-ди-АМФ). Для получения этого штамма в качестве клеток-реципиентов плазмиды pET42a+ со встроенным геном disA, кодирующим диаденилатциклазу B. thuringiensis, впервые были использованы клетки E. coli «Rosetta (DE3) pLysS». Клетки нового штамма способны продуцировать гетерологичную диаденилатциклазу, около 90 % которой локализовано во фракции каталитически активных телец включения. Продуцирующая способность полученного штамма в отношении диаденилатциклазы, находящейся в составе каталитически активных телец включения, составила 720 ед/л культуральной жидкости. Образуемые этим штаммом тельца включения могут быть использованы в технологии получения фармакологически перспективного цикло-ди-АМФ.</p></abstract><trans-abstract xml:lang="en"><p>Using the DNA recombination technique, a new bacterial strain Escherichia coli DAC-22 was derived, whose cells are able to carry out the heterologous expression of Bacillus thuringiensis diadenylate cyclase – the enzyme catalyzing the reaction of adenosine-5′-triphosphate (ATP) transformation into cyclic 3′,5′-diadenylate (cyclo-di-AMP). To derive the strain, E. coli “Rosetta (DE3) pLysS” cells were originally used as recipients of plasmid pET42a+ with the inserted gene disA encoding diadenylate cyclase of B. thuringiensis. The cells of the recombinant strain are able to produce heterologous diadenylate cyclase localized predominantly (by 90 %) in the fraction of the catalytically active inclusion bodies. The productivity of the new strain with respect to diadenylate cyclase structurally arranged as the inclusion bodies was 720 units/l of cultural fluid. The inclusion bodies formed by the newly engineered strain are intended for use in the technology of producing pharmacologically promising cyclo-di-AMP.</p></trans-abstract><kwd-group xml:lang="ru"><kwd>Escherichia coli</kwd><kwd>генная инженерия</kwd><kwd>рекомбинантный штамм</kwd><kwd>Bacillus thuringiensis</kwd><kwd>гетерологичная экспрессия гена</kwd><kwd>тельца включения</kwd><kwd>диаденилатциклаза</kwd><kwd>цикло-ди-АМФ</kwd></kwd-group><kwd-group xml:lang="en"><kwd>Escherichia coli</kwd><kwd>genetic engineering</kwd><kwd>recombinant strain</kwd><kwd>Bacillus thuringiensis</kwd><kwd>heterologous gene expression</kwd><kwd>inclusion bodies</kwd><kwd>diadenylate cyclase</kwd><kwd>cyclo-di-AMP</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">A decade of research on the second messenger c-di-AMP / W. Yin [et al.] // FEMS Microbiol. Rev. – 2020. – Vol. 44, N 6. – P. 701–724. https://doi.org/10.1093/femsre/fuaa019</mixed-citation><mixed-citation xml:lang="en">Yin W., Cai X., Ma H., Zhu L., Zhang Y., Chou S.-H., Galperin M. Y., He J. A decade of research on the second messenger c-di-AMP. FEMS Microbiology Reviews, 2020, vol. 44, no. 6, pp. 701–724. https://doi.org/10.1093/femsre/ fuaa019</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge / M. V. Sanchez [et al.] // PLoS ONE. – 2014. – Vol. 9, N 8. – Art. e104824. https://doi.org/10.1371/journal.pone.0104824</mixed-citation><mixed-citation xml:lang="en">Sanchez M. V., Ebensen T., Schulze K., Cargnelutti D., Blazejewska P., Scodeller E. A., Guzmán C. A. Intranasal delivery of influenza rNP adjuvanted with c-di-AMP induces strong humoral and cellular immune responses and provides protection against virus challenge. PLoS ONE, 2014, vol. 9, no. 8, art. e104824. https://doi.org/10.1371/journal. pone.0104824</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Cyclic di-adenosine monophosphate: a promising adjuvant candidate for the development of neonatal vaccines / D. Lirussi [et al.] // Pharmaceutics. – 2021. – Vol. 13, N 2. – Art. 188. https://doi.org/10.3390/ pharmaceutics13020188</mixed-citation><mixed-citation xml:lang="en">Lirussi D., Weissmann S. F., Ebensen T., Nitsche-Gloy U., Franz H. B. G., Guzman C. A. Cyclic di-adenosine monophosphate: a promising adjuvant candidate for the development of neonatal vaccines. Pharmaceutics, 2021, vol. 13, no. 2, art. 188. https://doi.org/10.3390/pharmaceutics13020188</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Yan, H. The Promise and challenges of cyclic dinucleotides as molecular adjuvants for vaccine development / H. Yan, W. Chen // Vaccines. – 2021. – Vol. 9, N 8. – Art. 917. https://doi.org/10.3390/vaccines9080917</mixed-citation><mixed-citation xml:lang="en">Yan H., Chen W. The promise and challenges of cyclic dinucleotides as molecular adjuvants for vaccine development. Vaccines, 2021, vol, 9, no. 8, art. 917. https://doi.org/10.3390/vaccines9080917</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Chemical synthesis, purification, and characterization of 3′-5′-linked canonical cyclic dinucleotides (CDNs) / C. Wang [et al.] // Meth. Enzymol. – 2019. – Vol. 625. – P. 41−59. https://doi.org/10.1016/bs.mie.2019.04.022</mixed-citation><mixed-citation xml:lang="en">Wang C., Hao M., Qi Q., Chen Y., Hartig J. S. Chemical synthesis, purification, and characterization of 3′-5′-linked canonical cyclic dinucleotides (CDNs). Methods in Enzymology, 2019, vol. 625, pp. 41−59. https://doi.org/10.1016/bs. mie.2019.04.022</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Villaverde, A. Protein aggregation in recombinant bacteria: Biological role of inclusion bodies / A. Villaverde, M. M. Carrio // Biotechnol. Lett. – 2003. – Vol. 25, N 17. – P. 1385–1395. https://doi.org/10.1023/a:1025024104862</mixed-citation><mixed-citation xml:lang="en">Villaverde A., Carrio M. M. Protein aggregation in recombinant bacteria: Biological role of inclusion bodies. Biotechnology Letters, 2003, vol, 25, no. 17, pp. 1385–1395. https://doi.org/10.1023/a:1025024104862</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Schramm, F. D. Protein aggregation in bacteria / F. D. Schramm, K. Schroeder, K. Jonas // FEMS Microbiol. Rev. – 2020. – Vol. 44, N 1. – P. 54–72. https://doi.org/10.1093/femsre/fuz026</mixed-citation><mixed-citation xml:lang="en">Schramm F. D., Schroeder K., Jonas K. Protein aggregation in bacteria. FEMS Microbiology Reviews, 2020, vol. 44, no. 1, pp. 54–72. https://doi.org/10.1093/femsre/fuz026</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Enzymatic synthesis of 2′-ara and 2′-deoxy analogues of c-di-GMP / A. S. Shchokolova [et al.] // Nucleos. Nucleot. Nucl. Acids. – 2015. – Vol. 34, N 6. – P. 416–423. https://doi.org/10.1080/15257770.2015.1006775</mixed-citation><mixed-citation xml:lang="en">Shchokolova A. S., Rymko A. N., Kvach S. V., Shabunya P. S., Fatykhava S. A., Zinchenko A. I. Enzymatic synthesis of 2′-ara and 2′-deoxy analogues of c-di-GMP. Nucleosides, Nucleotides and Nucleic Acids, 2015, vol. 34, no. 6, pp. 416–423. https://doi.org/10.1080/15257770.2015.1006775</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Thermostable adenosine 5′-monophosphate phosphorylase from Thermococcus kodakarensis forms catalytically active inclusion bodies / S. Kamel [et al.] // Sci. Rep. – 2021. – Vol. 11, N 1. – Art. 16880. https://doi.org/10.1038/s41598- 021-96073-5</mixed-citation><mixed-citation xml:lang="en">Kamel S., Walczak M. C., Kaspar F., Westarp S., Neubauer P., Kurreck A. Thermostable adenosine 5′-monophosphate phosphorylase from Thermococcus kodakarensis forms catalytically active inclusion bodies. Scientific Reports, 2021, vol. 11, no. 1, art. 16880. https://doi.org/10.1038/s41598-021-96073-5</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer / A. K. Singh [et al.] // Nat. Commun. – 2022. – Vol. 13, N 1. – Art. 878. https://doi.org/10.1038/s41467- 022-28509-z</mixed-citation><mixed-citation xml:lang="en">Singh A. K., Praharaj M., Lombardo K. A., Yoshida T., Matoso A., Baras A. S., Zhao L., Srikrishna G., Huang J., Prasad P., Powell J. D., Kates M., McConkey D., Pardoll D. M., Bishai W. R., Bivalacqua T. J. Re-engineered BCG overexpressing cyclic di-AMP augments trained immunity and exhibits improved efficacy against bladder cancer. Nature Communications, 2022, vol. 13, no. 1, art. 878. https://doi.org/10.1038/s41467-022-28509-z</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Cyclic di-AMP homeostasis in Bacillus subtilis: both lack and high level accumulation of the nucleotide are detrimental for cell growth / F. M. Mehne [et al.] // J. Biol. Chem. – 2013. – Vol. 288, N 3. – P. 2004–2017. https://doi.org/10.1074/jbc. m112.395491</mixed-citation><mixed-citation xml:lang="en">Mehne F. M., Gunka K., Eilers H., Herzberg C., Kaever V., Stülke J. Cyclic di-AMP homeostasis in Bacillus subtilis: both lack and high level accumulation of the nucleotide are detrimental for cell growth. Journal of Biological Chemistry, 2013, vol. 288, no. 3, pp. 2004−2017. https://doi.org/10.1074/jbc.m112.395491</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Создание рекомбинантного штамма Escherichia coli – продуцента диаденилатциклазы и ее использование для синтеза цикло-ди-АМФ / И. С. Казловский [и др.] // Вес. Нац. акад. навук Беларусi. Сер. бiял. навук. – 2015. – № 4. – С. 51–55.</mixed-citation><mixed-citation xml:lang="en">Kazlovskij I. S., Radevich D. S., Rymko A. N., Shchokolova А. S., Kvach S. V., Zinchenko A. I. Construction of Escherichia coli strain, producing di-adenylate cyclase and its application for cyclic di-AMP synthesis. Vestsi Natsyyanal’nai akademii navuk Belarusi. Seryya biyalagichnykh navuk = Proceedings of the National Academy of Sciences of Belarus. Biological series, 2015, no. 4, рр. 51–55 (in Russian).</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Green, M. R. Molecular cloning. A laboratory manual. 4th ed. / M. R. Green, J. Sambrook. – New York, 2012. – 630 p.</mixed-citation><mixed-citation xml:lang="en">Green M. R., Sambrook J. Molecular cloning: a laboratory manual, fourth ed. New York, 2012. 630 p.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Quan, J. Circular polymerase extension cloning of complex gene libraries and pathways / J. Quan, J. Tian // PLoS ONE. – 2009. – Vol. 4, N 7. – Art. e6441. https://doi.org/10.1371/journal.pone.0006441</mixed-citation><mixed-citation xml:lang="en">Quan J., Tian J. Circular polymerase extension cloning of complex gene libraries and pathways. PLoS ONE, 2009, vol. 4, no. 7, art. e6441. https://doi.org/10.1371/journal.pone.0006441</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Challenges associated with the formation of recombinant protein inclusion bodies in Escherichia coli and strategies to address them for industrial applications / A. Bhatwa [et al.] // Front. Bioeng. Biotechnol. – 2021. – Vol. 9. – Art. 630551. https:// doi.org/10.3389/fbioe.2021.630551</mixed-citation><mixed-citation xml:lang="en">Bhatwa A., Wang W., Hassan Y. I., Abraham N., Li X.-Z., Zhou T. Challenges associated with the formation of recombinant protein inclusion bodies in Escherichia coli and strategies to address them for industrial applications. Frontiers in Bioengineering and Biotechnology, 2021, vol. 9, art. 630551. https://doi.org/10.3389/fbioe.2021.630551</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
